top of page

Global Regulatory Toxicology Consulting

Let's chat about your project

Search

Development of bivalent RBD adapted COVID-19 vaccines for broad sarbecovirus immunity

jeanfrancoismaison
May 30
1 min read

https://pubmed.ncbi.nlm.nih.gov/40442110/

Recent Posts

ANGPTL3: A Breakthrough Target in Treatment for Dyslipidemia and Atherosclerosis

https://pubmed.ncbi.nlm.nih.gov/40467521/

Targeting CD117 on hematopoietic stem and progenitor cells impairs CAR T cell activity

https://pubmed.ncbi.nlm.nih.gov/40450523/

MDM2 inhibitors in sarcomas: results and next steps

https://pubmed.ncbi.nlm.nih.gov/40464483/

bottom of page